What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?

International Journal of Cardiology

Volumn 225, Issue , 2016, Pages 365-370

  Mesquita, Rafael ^a,b   Franssen, Frits M E ^a   Houben Wilke, Sarah ^a   Uszko Lencer, Nicole H M K ^a,b   Vanfleteren, Lowie E G W ^a,b   Goërtz, Yvonne M J ^a   Pitta, Fabio ^c   Wouters, Emiel F M ^a,b   Spruit, Martijn A ^a  

^a Center of Expertise for Chronic Organ Failure   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Chronic heart failure; Chronic obstructive pulmonary disease; Comorbidity; Outcome assessment (health care)

Indexed keywords

ADULT; AGE; AGED; ANXIETY; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MUSCLE FUNCTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SEX; SIX MINUTE WALK TEST; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; EXERCISE TOLERANCE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WALK TEST;

ABSORPTIOMETRY, PHOTON; AGED; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WALK TEST;

EID: 84991704918     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.10.016     Document Type: Article

References (39)

1. [1] Hawkins, N.M., Petrie, M.C., Jhund, P.S., Chalmers, G.W., Dunn, F.G., McMurray, J.J., Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur. J. Heart Fail. 11:2 (2009), 130–139.
2. [2] Miller, J., Edwards, L.D., Agusti, A., Bakke, P., Calverley, P.M., Celli, B., Coxson, H.O., Crim, C., Lomas, D.A., Miller, B.E., Rennard, S., Silverman, E.K., Tal-Singer, R., Vestbo, J., Wouters, E., Yates, J.C., Macnee, W., Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) investigators. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir. Med. 107:9 (2013), 1376–1384.
3. [3] Mapel, D.W., Dedrick, D., Davis, K., Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration Medical System, 1991–1999. COPD 2:1 (2005), 35–41.
4. [4] Gosker, H.R., Lencer, N.H., Franssen, F.M., van der Vusse, G.J., Wouters, E.F., Schols, A.M., Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 123:5 (2003), 1416–1424.
5. [5] Patel, A.R., Donaldson, G.C., Mackay, A.J., Wedzicha, J.A., Hurst, J.R., The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD. Chest 141:4 (2012), 851–857.
6. [6] Putcha, N., MK, H., CH, M., MG, F., AR, A., Casaburi, R., MH, C., NA, H., CP, H., GL, K., BJ, M., RM, S., SM, L., BM, T., AA, W., SP, B., TH, B., RP, B., JW, R., JL, C., Everett, D., JE, H., DA, L., ER, S., EK, S., JD, C., RA, W., EA, R., NN, H., the COPDGene® Investigators. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. Chron. Obstruct. Pulmon. Dis. 1:1 (2014), 105–114.
7. [7] Oliveira, M.F., FF, A., MC, A., Souza, A., PA, S., WM, M., Mazzuco, A., Borghi-Silva, A., LA, M., Santos, R., DM, H., Mancuso, F., Almeida, D., DE, O.’.D., JA, N., Heart failure impairs muscle blood flow and endurance exercise tolerance in COPD. COPD 13:4 (2016), 407–415.
8. [8] Smid, D.E., Wilke, S., Jones, P.W., Muris, J.W., Wouters, E.F., Franssen, F.M., Spruit, M.A., Impact of cardiovascular comorbidities on COPD assessment test (CAT) and its responsiveness to pulmonary rehabilitation in patients with moderate to very severe COPD: protocol of the chance study. BMJ Open, 5(7), 2015, e007536.
9. [9] Vestbo, J., Hurd, S.S., Agusti, A.G., Jones, P.W., Vogelmeier, C., Anzueto, A., Barnes, P.J., Fabbri, L.M., Martinez, F.J., Nishimura, M., Stockley, R.A., Sin, D.D., Rodriguez-Roisin, R., Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 187:4 (2013), 347–365.
10. [10] Spruit, M.A., Vanderhoven-Augustin, I., Janssen, P.P., Wouters, E.F., Integration of pulmonary rehabilitation in COPD. Lancet 371:9606 (2008), 12–13.
11. [11] Holland, A.E., Spruit, M.A., Troosters, T., Puhan, M.A., Pepin, V., Saey, D., McCormack, M.C., Carlin, B.W., Sciurba, F.C., Pitta, F., Wanger, J., MacIntyre, N., Kaminsky, D.A., Culver, B.H., Revill, S.M., Hernandes, N.A., Andrianopoulos, V., Camillo, C.A., Mitchell, K.E., Lee, A.L., Hill, C.J., Singh, S.J., An official European Respiratory Society/American Thoracic Society Technical Standard: field walking tests in chronic respiratory disease. Eur. Respir. J. 44:6 (2014), 1428–1446.
12. [12] ATS/ACCP Statement on cardiopulmonary exercise testing, Am. J. Respir. Crit. Care Med. 167:2 (2003), 211–277.
13. [13] van ‘t Hul, A., Gosselink, R., Kwakkel, G., Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J. Cardpulm. Rehabil. 23:2 (2003), 143–150.
14. [14] Sillen, M.J., Franssen, F.M., Delbressine, J.M., Uszko-Lencer, N.H., Vanfleteren, L.E., Rutten, E.P., Wouters, E.F., Spruit, M.A., Heterogeneity in clinical characteristics and co-morbidities in dyspneic individuals with COPD GOLD D: findings of the DICES trial. Respir. Med. 107:8 (2013), 1186–1194.
15. [15] Mesquita, R., Janssen, D.J., Wouters, E.F., Schols, J.M., Pitta, F., Spruit, M.A., Within-day test-retest reliability of the timed up & go test in patients with advanced chronic organ failure. Arch. Phys. Med. Rehabil. 94:11 (2013), 2131–2138.
16. [16] Mesquita, R., Wilke, S., Smid, D.E., Janssen, D.J., Franssen, F.M., Probst, V.S., EF, W., JW, M., Pitta, F., MA, S., Measurement properties of the timed up & go test in patients with COPD. Chron. Respir. Dis., 2016, 10.1177/1479972316647178.
17. [17] Jones, P.W., Harding, G., Berry, P., Wiklund, I., Chen, W.H., Kline, L.N., Development and first validation of the COPD assessment test. Eur. Respir. J. 34:3 (2009), 648–654.
18. [18] Meguro, M., Barley, E.A., Spencer, S., Jones, P.W., Development and validation of an improved, COPD-specific version of the St. George Respiratory Questionnaire. Chest 132:2 (2007), 456–463.
19. [19] Dijkstra, A., Tiesinga, L.J., Goossen, W.T., Dassen, T.W., Further psychometric testing of the Dutch care dependency scale on two different patient groups. Int. J. Nurs. Pract. 8:6 (2002), 305–314.
20. [20] Zigmond, A.S., Snaith, R.P., The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67:6 (1983), 361–370.
21. [21] Franssen, F.M., Rutten, E.P., Groenen, M.T., Vanfleteren, L.E., Wouters, E.F., Spruit, M.A., New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J. Am. Med. Dir. Assoc., 15(6), 2014 (448 e441-446).
22. [22] Janssen, D.J., Wouters, E.F., Schols, J.M., Spruit, M.A., Care dependency independently predicts two-year survival in outpatients with advanced chronic organ failure. J. Am. Med. Dir. Assoc. 14:3 (2013), 194–198.
23. [23] Berry, C.E., Wise, R.A., Mortality in COPD: causes, risk factors, and prevention, COPD., 7(5), 2010, 375–382.
24. [24] Spruit, M.A., Polkey, M.I., Celli, B., Edwards, L.D., Watkins, M.L., Pinto-Plata, V., Vestbo, J., Calverley, P.M., Tal-Singer, R., Agusti, A., Coxson, H.O., Lomas, D.A., MacNee, W., Rennard, S., Silverman, E.K., Crim, C.C., Yates, J., Wouters, E.F., Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J. Am. Med. Dir. Assoc. 13:3 (2012), 291–297.
25. [25] Barnes, P.J., Celli, B.R., Systemic manifestations and comorbidities of COPD. Eur. Respir. J. 33:5 (2009), 1165–1185.
26. [26] Bailey, K.L., The importance of the assessment of pulmonary function in COPD. Med. Clin North Am. 96:4 (2012), 745–752.
27. [27] Siegel, J.L., Miller, A., Brown, L.K., DeLuca, A., Teirstein, A.S., Pulmonary diffusing capacity in left ventricular dysfunction. Chest 98:3 (1990), 550–553.
28. [28] Sabit, R., Bolton, C.E., Fraser, A.G., Edwards, J.M., Edwards, P.H., Ionescu, A.A., Cockcroft, J.R., Shale, D.J., Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir. Med. 104:8 (2010), 1171–1178.
29. [29] Burgess, M.I., Mogulkoc, N., Bright-Thomas, R.J., Bishop, P., Egan, J.J., Ray, S.G., Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease. J. Am. Soc.Echocardiogr. 15:6 (2002), 633–639.
30. [30] Rudski, L.G., Lai, W.W., Afilalo, J., Hua, L., Handschumacher, M.D., Chandrasekaran, K., Solomon, S.D., Louie, E.K., NB, S., Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 23:7 (2010), 685–713 (quiz 786-688).
31. [31] Maltais, F., Decramer, M., Casaburi, R., Barreiro, E., Burelle, Y., Debigare, R., PN, D., Franssen, F., Gayan-Ramirez, G., Gea, J., HR, G., Gosselink, R., Hayot, M., SN, H., Janssens, W., MI, P., Roca, J., Saey, D., AM, S., MA, S., Steiner, M., Taivassalo, T., Troosters, T., Vogiatzis, I., PD, W., ATS/ERS Ad Hoc committee on limb muscle dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 189:9 (2014), e15–e62.
32. [32] Jones, P.W., St. George's Respiratory Questionnaire: MCID. COPD 2:1 (2005), 75–79.
33. [33] de Voogd, J.N., Wempe, J.B., Koeter, G.H., Postema, K., van Sonderen, E., Ranchor, A.V., Coyne, J.C., Sanderman, R., Depressive symptoms as predictors of mortality in patients with COPD. Chest 135:3 (2009), 619–625.
34. [34] Mesquita, R., Vanfleteren, L.E., Franssen, F.M., Sarv, J., Taib, Z., Groenen, M.T., Gaffron, S., Bruijnzeel, P.L., Pitta, F., Wouters, E.F., Spruit, M.A., Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes. Eur. Respir. J. 46:2 (2015), 545–548.
35. [35] Mezzani, A., Hamm, L.F., Jones, A.M., McBride, P.E., Moholdt, T., Stone, J.A., Urhausen, A., Williams, M.A., Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation, and the Canadian Association of Cardiac Rehabilitation. J. Cardiopulm. Rehabil. Prev. 32:6 (2012), 327–350.
36. [36] Triest, F.J., Franssen, F.M., Spruit, M.A., Groenen, M.T., Wouters, E.F., Vanfleteren, L.E., Poor agreement between chart-based and objectively identified comorbidities of COPD. Eur. Respir. J. 46:5 (2015), 1492–1495.
37. [37] Bisca, G.W., Proenca, M., Salomao, A., Hernandes, N.A., Pitta, F., Minimal detectable change of the London chest activity of daily living scale in patients with COPD. J. Cardiopulm. Rehabil. Prev. 34:3 (2014), 213–216.
38. [38] Demeyer, H., Burtin, C., Hornikx, M., Camillo, C.A., Van Remoortel, H., Langer, D., Janssens, W., Troosters, T., The minimal important difference in physical activity in patients with COPD. PLoS ONE, 11(4), 2016, e0154587.
39. [39] Laviolette, L., Bourbeau, J., Bernard, S., Lacasse, Y., Pepin, V., Breton, M.J., Baltzan, M., Rouleau, M., Maltais, F., Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 63:2 (2008), 115–121.